(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Gen Z workplace stereotypes were TV’s favorite punchline in 2025 - 2One spent $20 on candy. Another paid $700 for a custom costume. Here's how Halloween costs stacked up this year.
- 3Track down the Ideal Weight reduction Methodology for Your Way of life
- 4Woman charged in unprovoked stabbing of tourist changing baby's diaper in Macy’s Herald Square store
- 5Etymological Experiences on the Wireless transmissions: A Survey of \Learning in a hurry\ Language Web recording
- Solar storms can trigger auroras on Earth. This star’s explosion could destroy a planet’s atmosphere
- Full SNAP benefits must be paid ‘promptly,’ USDA tells states as government reopens
- Idris Elba is the king of the stress-watch
- Agricultural drones are taking off globally, saving farmers time and money
- Your guide to how to safely thaw and cook your Thanksgiving turkey this year, according to experts
- 4 Must-Visit bar-b-que Eateries This Year
- Overseeing Individual budgets Successfully
- A decade after Brazil’s deadly dam collapse, Indigenous peoples demand justice on the eve of COP30
- 'The Beast in Me' arrives on Netflix: Is it based on a true story? And what drew Claire Danes to it? What to know about the thriller series.
